Showing 61 to 72 of 75 results


Flash Therapy: A Revolutionary Cancer Treatment
Researchers at CERN are developing flash therapy, a new cancer treatment using proton beams to destroy tumors in milliseconds with minimal damage to healthy tissues, potentially replacing traditional radiation therapy and offering advantages for treating brain and other hard-to-reach cancers.
Flash Therapy: A Revolutionary Cancer Treatment
Researchers at CERN are developing flash therapy, a new cancer treatment using proton beams to destroy tumors in milliseconds with minimal damage to healthy tissues, potentially replacing traditional radiation therapy and offering advantages for treating brain and other hard-to-reach cancers.
Progress
48% Bias Score


Hepatitis Outbreak at Kamchatka Oncology Dispensary: 36 Cases, Criminal Investigation Launched
Thirty-six patients in Kamchatka's regional oncology dispensary contracted acute viral hepatitis B and C after undergoing CT scans; investigations revealed violations in sterilization and antiseptic protocols, leading to a criminal negligence case and the temporary closure of the CT department.
Hepatitis Outbreak at Kamchatka Oncology Dispensary: 36 Cases, Criminal Investigation Launched
Thirty-six patients in Kamchatka's regional oncology dispensary contracted acute viral hepatitis B and C after undergoing CT scans; investigations revealed violations in sterilization and antiseptic protocols, leading to a criminal negligence case and the temporary closure of the CT department.
Progress
32% Bias Score


Secondary Breast Cancer: Improved Treatments Offer Hope, but Early Detection Remains Crucial
Two women, Hannah Gardner and Natalie Gibbs, share their experiences with secondary breast cancer, highlighting the often-unclear symptoms, delayed diagnoses, and recent advancements in treatment that are extending survival rates and changing the approach to managing this stage of cancer.
Secondary Breast Cancer: Improved Treatments Offer Hope, but Early Detection Remains Crucial
Two women, Hannah Gardner and Natalie Gibbs, share their experiences with secondary breast cancer, highlighting the often-unclear symptoms, delayed diagnoses, and recent advancements in treatment that are extending survival rates and changing the approach to managing this stage of cancer.
Progress
44% Bias Score


South Korean 'Reverse Therapy' for Cancer: Hype or Hope?
South Korean scientists announced a novel 'reverse therapy' that reportedly transforms cancerous cells into normal ones, but its clinical efficacy needs confirmation, potentially offering a supplementary approach to existing cancer treatments.
South Korean 'Reverse Therapy' for Cancer: Hype or Hope?
South Korean scientists announced a novel 'reverse therapy' that reportedly transforms cancerous cells into normal ones, but its clinical efficacy needs confirmation, potentially offering a supplementary approach to existing cancer treatments.
Progress
52% Bias Score


Russia Begins Human Trials of Personalized Cancer Vaccine
Russia is conducting human clinical trials for "EnteroMix," a personalized cancer vaccine using oncolytic viruses, targeting patients with solid tumors who have exhausted standard treatment options, offering a potentially revolutionary approach to cancer treatment.
Russia Begins Human Trials of Personalized Cancer Vaccine
Russia is conducting human clinical trials for "EnteroMix," a personalized cancer vaccine using oncolytic viruses, targeting patients with solid tumors who have exhausted standard treatment options, offering a potentially revolutionary approach to cancer treatment.
Progress
44% Bias Score


Ten Early Warning Signs of Cancer: Professor Drapkina's Urgent Warning
Professor Oksana Drapkina lists ten potential early cancer symptoms: unexplained weight loss, fatigue, persistent cough, swallowing difficulties, enlarged lymph nodes, chronic pain, skin changes, digestive issues, urinary problems, and unexplained bleeding; early detection is crucial for successful ...
Ten Early Warning Signs of Cancer: Professor Drapkina's Urgent Warning
Professor Oksana Drapkina lists ten potential early cancer symptoms: unexplained weight loss, fatigue, persistent cough, swallowing difficulties, enlarged lymph nodes, chronic pain, skin changes, digestive issues, urinary problems, and unexplained bleeding; early detection is crucial for successful ...
Progress
36% Bias Score

Shortage of Cancer Drugs at Skopje Oncology Clinic Impacts Patient Care
Due to administrative procedures and increased patient numbers, six crucial biological cancer therapies are unavailable at Skopje's Oncology Clinic, impacting treatment for patients since January 17th, 2024, prompting calls for improved resource allocation and patient management.

Shortage of Cancer Drugs at Skopje Oncology Clinic Impacts Patient Care
Due to administrative procedures and increased patient numbers, six crucial biological cancer therapies are unavailable at Skopje's Oncology Clinic, impacting treatment for patients since January 17th, 2024, prompting calls for improved resource allocation and patient management.
Progress
44% Bias Score

Galapagos Restructures, Splits into Two, Cuts 300 Jobs
Galapagos, a Dutch-Belgian biotech firm facing financial struggles after setbacks in US market approvals, is splitting into two entities: one focusing on oncology cell therapy, and SpinCo, receiving \u20ac2.45 billion for acquisitions, resulting in 300 job cuts and separation from a restrictive agre...

Galapagos Restructures, Splits into Two, Cuts 300 Jobs
Galapagos, a Dutch-Belgian biotech firm facing financial struggles after setbacks in US market approvals, is splitting into two entities: one focusing on oncology cell therapy, and SpinCo, receiving \u20ac2.45 billion for acquisitions, resulting in 300 job cuts and separation from a restrictive agre...
Progress
40% Bias Score

J&J's Lung Cancer Drug Extends Life by at Least a Year
Johnson & Johnson announced Tuesday that its two-drug lung cancer regimen, Rybrevant and Lazcluze, extends life expectancy by at least a year compared to AstraZeneca's Tagrisso, based on a pivotal trial, though the regimen has more side effects.

J&J's Lung Cancer Drug Extends Life by at Least a Year
Johnson & Johnson announced Tuesday that its two-drug lung cancer regimen, Rybrevant and Lazcluze, extends life expectancy by at least a year compared to AstraZeneca's Tagrisso, based on a pivotal trial, though the regimen has more side effects.
Progress
60% Bias Score

Nanoparticle Drug Delivery Boosts Cancer Treatment Effectiveness
Tel Aviv University researchers created nanoparticles delivering two cancer-fighting drugs simultaneously to tumors, increasing effectiveness and reducing side effects; animal tests showed tumors shrank significantly, and mice lived up to three times longer than untreated mice.

Nanoparticle Drug Delivery Boosts Cancer Treatment Effectiveness
Tel Aviv University researchers created nanoparticles delivering two cancer-fighting drugs simultaneously to tumors, increasing effectiveness and reducing side effects; animal tests showed tumors shrank significantly, and mice lived up to three times longer than untreated mice.
Progress
32% Bias Score

Russia Announces Free Personalized Cancer Vaccine for 2025 Rollout
Russia's health ministry announced a free, personalized cancer vaccine for patients, launching in early 2025, addressing the nation's rising cancer rates exceeding 635,000 cases in 2022, using RNA technology similar to Western approaches.

Russia Announces Free Personalized Cancer Vaccine for 2025 Rollout
Russia's health ministry announced a free, personalized cancer vaccine for patients, launching in early 2025, addressing the nation's rising cancer rates exceeding 635,000 cases in 2022, using RNA technology similar to Western approaches.
Progress
32% Bias Score

World-First Personalized mRNA Cancer Vaccine Shows Promise in Treating Urinary Tract Cancer
A 75-year-old woman at Bari's Policlinico hospital became the first globally to receive a personalized mRNA cancer vaccine (cevumeran) alongside nivolumab immunotherapy after surgery for high-risk urinary tract cancer; this innovative treatment is designed to address specific tumor mutations, offeri...

World-First Personalized mRNA Cancer Vaccine Shows Promise in Treating Urinary Tract Cancer
A 75-year-old woman at Bari's Policlinico hospital became the first globally to receive a personalized mRNA cancer vaccine (cevumeran) alongside nivolumab immunotherapy after surgery for high-risk urinary tract cancer; this innovative treatment is designed to address specific tumor mutations, offeri...
Progress
56% Bias Score
Showing 61 to 72 of 75 results